Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Current Assets (2016 - 2026)

Champions Oncology has reported Current Assets over the past 16 years, most recently at $20.2 million for Q1 2026.

  • Quarterly results put Current Assets at $20.2 million for Q1 2026, up 2.48% from a year ago — trailing twelve months through Jan 2026 was $20.2 million (up 2.48% YoY), and the annual figure for FY2025 was $22.4 million, up 63.93%.
  • Current Assets for Q1 2026 was $20.2 million at Champions Oncology, down from $21.3 million in the prior quarter.
  • Over the last five years, Current Assets for CSBR hit a ceiling of $22.4 million in Q2 2025 and a floor of $13.2 million in Q3 2024.
  • Median Current Assets over the past 5 years was $19.5 million (2023), compared with a mean of $17.9 million.
  • Biggest five-year swings in Current Assets: plummeted 35.17% in 2024 and later skyrocketed 63.93% in 2025.
  • Champions Oncology's Current Assets stood at $20.6 million in 2022, then tumbled by 31.98% to $14.0 million in 2023, then grew by 0.48% to $14.1 million in 2024, then skyrocketed by 51.46% to $21.3 million in 2025, then dropped by 5.38% to $20.2 million in 2026.
  • The last three reported values for Current Assets were $20.2 million (Q1 2026), $21.3 million (Q4 2025), and $21.0 million (Q3 2025) per Business Quant data.